Terms: = Uterine cancer AND TFRC, P02786, 7037, ENSG00000072274, TFR1, CD71
17 results:
1. Development and validation of a prognostic model for cervical cancer by combination of machine learning and high-throughput sequencing.
Shi R; Chang L; Shi L; Zhang Z; Zhang L; Li X
Eur J Surg Oncol; 2024 Apr; 50(4):108241. PubMed ID: 38452717
[TBL] [Abstract] [Full Text] [Related]
2. Identification of ferroptosis-related molecular subtypes and a methylation-related ferroptosis gene prognostic signature in cervical squamous cell carcinoma.
Yu L; Gao Z; Li Z; Liu P; Gao Y; Liang G
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14673-14689. PubMed ID: 37584713
[TBL] [Abstract] [Full Text] [Related]
3. Transferrin receptor modulated by microRNA-497-5p suppresses cervical cancer cell malignant phenotypes.
Fang X; Hu P; Gao Y; Chen C; Xu J
Adv Clin Exp Med; 2024 Mar; 33(3):273-282. PubMed ID: 37486696
[TBL] [Abstract] [Full Text] [Related]
4. Artemisia argyi H.Lév. & Vaniot essential oil induces ferroptosis in pancreatic cancer cells via up-regulation of tfr1 and depletion of γ-glutamyl cycle.
Zhang N; Zhang J; Cui W; Wu D; Zhang J; Wei B; Qu L; Xu X
Fitoterapia; 2023 Jul; 168():105522. PubMed ID: 37169131
[TBL] [Abstract] [Full Text] [Related]
5. A Novel Immune-Related Signature to Predict Prognosis and Immune Infiltration of Cervical cancer.
Lin Y; Zhang R; Pan H; Li Y
Med Sci Monit; 2023 Mar; 29():e938660. PubMed ID: 36973995
[TBL] [Abstract] [Full Text] [Related]
6. Iron metabolism protein transferrin receptor 1 involves in cervical cancer progression by affecting gene expression and alternative splicing in HeLa cells.
Huang N; Wei Y; Cheng Y; Wang X; Wang Q; Chen D; Li W
Genes Genomics; 2022 Jun; 44(6):637-650. PubMed ID: 35066810
[TBL] [Abstract] [Full Text] [Related]
7. Immunogenomic Identification for Predicting the Prognosis of Cervical cancer Patients.
Wang Q; Vattai A; Vilsmaier T; Kaltofen T; Steger A; Mayr D; Mahner S; Jeschke U; Hildegard Heidegger H
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671013
[TBL] [Abstract] [Full Text] [Related]
8. cd71
Leung TH; Tang HW; Siu MK; Chan DW; Chan KK; Cheung AN; Ngan HY
Mol Cancer Res; 2019 Sep; 17(9):1867-1880. PubMed ID: 31235657
[TBL] [Abstract] [Full Text] [Related]
9. Transferrin receptor-involved HIF-1 signaling pathway in cervical cancer.
Xu X; Liu T; Wu J; Wang Y; Hong Y; Zhou H
Cancer Gene Ther; 2019 Nov; 26(11-12):356-365. PubMed ID: 30651591
[TBL] [Abstract] [Full Text] [Related]
10. Preserved miR-361-3p Expression Is an Independent Prognostic Indicator of Favorable Survival in Cervical cancer.
Liu S; Song L; Yao H; Zhang L; Xu D; Li Q; Li Y
Dis Markers; 2018; 2018():8949606. PubMed ID: 30344797
[TBL] [Abstract] [Full Text] [Related]
11. Integrated analysis of HPV-mediated immune alterations in cervical cancer.
Chen L; Luan S; Xia B; Liu Y; Gao Y; Yu H; Mu Q; Zhang P; Zhang W; Zhang S; Wei G; Yang M; Li K
Gynecol Oncol; 2018 May; 149(2):248-255. PubMed ID: 29572030
[TBL] [Abstract] [Full Text] [Related]
12. Desferal regulates hCtr1 and transferrin receptor expression through Sp1 and exhibits synergistic cytotoxicity with platinum drugs in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo.
Chen SJ; Kuo CC; Pan HY; Tsou TC; Yeh SC; Chang JY
Oncotarget; 2016 Aug; 7(31):49310-49321. PubMed ID: 27384479
[TBL] [Abstract] [Full Text] [Related]
13. Signs and Symptoms of Venous Thromboembolism and Survival Outcome of Endometrial cancer.
Machida H; Hom MS; Maeda M; Yeo JJ; Ghattas CS; Grubbs BH; Matsuo K
Int J Gynecol Cancer; 2016 Jun; 26(5):924-32. PubMed ID: 27051051
[TBL] [Abstract] [Full Text] [Related]
14. Cervical cancer Stem Cells Selectively Overexpress HPV Oncoprotein E6 that Controls Stemness and Self-Renewal through Upregulation of HES1.
Tyagi A; Vishnoi K; Mahata S; Verma G; Srivastava Y; Masaldan S; Roy BG; Bharti AC; Das BC
Clin Cancer Res; 2016 Aug; 22(16):4170-84. PubMed ID: 26988248
[TBL] [Abstract] [Full Text] [Related]
15. Side populations from cervical-cancer-derived cell lines have stem-cell-like properties.
Villanueva-Toledo J; Ponciano-Gómez A; Ortiz-Sánchez E; Garrido E
Mol Biol Rep; 2014; 41(4):1993-2004. PubMed ID: 24420854
[TBL] [Abstract] [Full Text] [Related]
16. First study of oral Artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers.
Jansen FH; Adoubi I; J C KC; DE Cnodder T; Jansen N; Tschulakow A; Efferth T
Anticancer Res; 2011 Dec; 31(12):4417-22. PubMed ID: 22199309
[TBL] [Abstract] [Full Text] [Related]
17. Microarray analysis of normal cervix, carcinoma in situ, and invasive cervical cancer: identification of candidate genes in pathogenesis of invasion in cervical cancer.
Song JY; Lee JK; Lee NW; Jung HH; Kim SH; Lee KW
Int J Gynecol Cancer; 2008; 18(5):1051-9. PubMed ID: 18217980
[TBL] [Abstract] [Full Text] [Related]
